37 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof" "UNIS" PhD positions in Switzerland
Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
science. Further information about our research can be found on our website. Responsibilities You will develop and apply innovative genetic code expansion tools to achieve site-selective incorporation
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD position: Development of catalysts for CO2 hydrogenation to higher
-
international summer schools and present your research at workshops and scientific conferences. Publish multiple high-impact publications and collaborate with partner groups at the University of Cambridge (U.K
-
industrial firms throughout Europe. She/he will be supported by two mentors within the SPACER project, and will have multiple opportunities to participate in professional and personal development training
-
of coherence in coupled frequency comb lasers. A major open challenge is how to combine multiple comb sources into a single coherent system, overcoming fabrication-induced detuning of the repetition rate and
-
. Empa is a research institution of the ETH Domain. Empa’s Laboratory of Biomimetic Membranes and Textiles develops novel smart fibers, textiles and membranes for body monitoring, drug delivery and tissue
-
is the development ferroelectric lead free ceramics sintered below 500°C and the analysis of their mechanical and electromechanical properties of elastomers with piezoelectric properties using 3D
-
, networking, and career development are located in Basel. Basel provides a high standard of living and a rich and varied cultural atmosphere.
-
environment We offer Mentoring and support for professional and personal development A stimulating, multicultural research environment with access to state-of-the-art facilities Opportunities
-
well as to develop radically new therapies for eye diseases. These therapies are urgently needed, since the prevalence of visual diseases is rising globally, and effective therapies are lacking for most of them. As